1-19 of 19
Luca De Rosa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long Term Survival in Multiple Myeloma Patients: A Multicenter Italian Experience

Francesca Fazio, Martina Gherardini, Tommaso Za, Elena Rossi, Francesca Di Landro, Sonia Morè, Maria Valentina Manieri, Francesca Fioritoni, Velia Bongarzoni, Svitlana Gumenyuk, Angela Rago, Maria Grazia Garzia, Stefano Angelini, Chiara Masucci, Luca Franceschini, Alfonso Piciocchi, Piero Galieni, Luca De Rosa, Francesco Pisani, Stefano Pulini, Massimo Offidani, Valerio De Stefano, Maurizio Martelli, Maria Teresa Petrucci
Journal: Blood
Blood (2022) 140 (Supplement 1): 7147–7149.
https://doi.org/10.1182/blood-2022-165338
Published: 2022
Journal Articles

Consolidation Treatment with VRD Followed By Maintenance Therapy Versus Maintenance Alone in Newly Diagnosed, Transplant-Eligible Patients with Multiple Myeloma (MM): A Randomized Phase 3 Trial of the European Myeloma Network (EMN02/HO95)

Pieter Sonneveld, MD PhD, Meral Beksac, MD, Bronno Van Der Holt, PhD, Meletios A Dimopoulos, Angelo Michele Carella, MD, Heinz Ludwig, MD, Sonja Zweegman, MD PhD, Thilo Zander, MD, Ruth Wester, MD, Roman Hajek, MD, Lucia Pantani, MD PhD, Luca Dozza, MSc, Francesca Gay, MD, Anna Maria Cafro, Luca De Rosa, Francesca Fioritoni, MD, Ulf-Henrik Mellqvist, MD PhD, Rossella Troia, PharmD, Niels Frost Andersen, MD PhD, Ka Lung Wu, MD PhD, Christoph Driessen, MD, Susana Carvalho, MD, Alexandra J. Croockewit, MD PhD, Fredrik Schjesvold, MDPhD, Massimo Offidani, Michele Cavo, Mario Boccadoro
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–48.
https://doi.org/10.1182/blood-2020-139337
Published: 2020
Journal Articles

Impact of Minimal Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC) and Next-Generation Sequencing (NGS) on Outcome: Results of Newly Diagnosed Transplant-Eligible Multiple Myeloma (MM) Patients Enrolled in the Forte Trial

Stefania Oliva, Elisa Genuardi, Maria Teresa Petrucci, Mattia D'Agostino, MD, Daniel Auclair, Antonio Spadano, Allison P. Jacob, Michele Cea, Luca De Rosa, Alessandro Gozzetti, Marina Ruggeri, Andrea Capra, Milena Gilestro, Norbert Pescosta, Angelo D. Palmas, Agostina Siniscalchi, Ilan R. Kirsch, Paolo Corradini, Pellegrino Musto, Mario Boccadoro, Elena Zamagni, Francesca Gay, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-137351
Published: 2020
Journal Articles

Integrative Analysis of Baseline Prognostic Features and Achievement of Minimal Residual Disease Negativity As Predictors of Early Relapse in Transplant-Eligible Multiple Myeloma Patients

Francesca Gay, MD, Gian Maria Zaccaria, Massimo Offidani, Federico Vozella, Paolo Becco, Angelo Belotti, Andrea Capra, Monica Galli, Fortunato Morabito, Luca Bertamini, Francesco Pisani, Piero Galieni, Rita Rizzi, Alessandro Gozzetti, Norbert Pescosta, Luca De Rosa, Franco Narni, Milena Gilestro, Salvatore Palmieri, Michele Cea, Patrizia Tosi, Nicola Giuliani, Pellegrino Musto, Michele Cavo, Mario Boccadoro
Journal: Blood
Blood (2019) 134 (Supplement_1): 605.
https://doi.org/10.1182/blood-2019-125588
Published: 2019
Journal Articles

Immunotherapy in Multiple Myeloma: Experience of the Multiple Myeloma Gimema Lazio Group

Federico Vozella, MD, Agostina Siniscalchi, MD, Manuela Rizzo, MD, Tommaso Za, MD, Giusy Antolino, MD, Ugo Coppetelli, MD, Alfonso Piciocchi, Alessandro Andriani, MD, Ombretta Annibali, MD, Luca De Rosa, Giuseppe Cimino, Giacinto La Verde, Valerio De Stefano, MD, Maria Cantonetti, MD, Tommaso Caravita di Toritto, MD, Robin Foà, MD, Maria Teresa Petrucci, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5634.
https://doi.org/10.1182/blood-2018-99-115463
Published: 2018
Journal Articles

Definition of a Prognostic Risk-Classifier Based on SNPs Array Analysis of Copy Number Alterations in Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients

Carolina Terragna, Vincenza Solli, Andrea Poletti, Barbara Santacroce, Marina Martello, Alessandra Larocca, Luca Dozza, Anna Baraldi, MD, Lucia Pantani, MD, Adelina Sementa, Paola Tacchetti, MD, Norbert Pescosta, MD, Elena Zamagni, MD, Giovanna Leonardi, Caterina Musolino, MD, Giulia Marzocchi, BSc, Letizia Canepa, MD, Gaia Ameli, BSc, Beatrice Zannetti, Anna Pascarella, Enrica Borsi, Luca De Rosa, Nicoletta Testoni, BSc, Giovanni Martinelli, MD, Pieter Sonneveld, MDPhD, Michele Cavo, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3053.
https://doi.org/10.1182/blood.V130.Suppl_1.3053.3053
Published: 2017
Journal Articles

Consolidation Followed By Maintenance Therapy Versus Maintenance Alone in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma (MM): A Randomized Phase 3 Study of the European Myeloma Network (EMN02/HO95 MM Trial)

Pieter Sonneveld, MDPhD, Meral Beksac, Professor, Bronno van der Holt, PhD, Meletios A. Dimopoulos, Angelo Michele Carella, Heinz Ludwig, Christoph Driessen, MD PhD, Ruth Wester, Roman Hajek, Sandra Croockewit, Rossella Troia, Francesca Gay, MD, Anna Maria Cafro, Luca De Rosa, G Fioritoni, MD, Ulf-Henrik Mellqvist, Hans Erik Johnsen, MDDMSc, Sonja Zweegman, MD PhD, Ka Lung Wu, Joana Parreira, MD, Fredrik H. Schjesvold, MD, James D'Rozario, Antonio Palumbo, MD, Michele Cavo
Journal: Blood
Blood (2016) 128 (22): 242.
https://doi.org/10.1182/blood.V128.22.242.242
Published: 2016
Journal Articles

Virtual Karyotype Reconstruction By SNPs Array of Newly Diagnosed Multiple Myeloma (MM) Patients Enrolled in the EMN02 Clinical Trial

Carolina Terragna, PhD, Angela Flores Dico, Marina Martello, PhD, Vincenzo Callea, MD, Gioacchino Catania, MD, Tonino Spadano, MD, Tommaso Caravita di Toritto, Nicoletta Testoni, BSc, Anders Waage, MD PhD, Enrica Borsi, PhD, Antonio Palumbo, MD, Sonja Zweegman, MD PhD, Annamaria Cafro, MD, Angelo D. Palmas, MD, Silvestro Volpe, MD, Marcella Prete, MD, Ernesto Vigna, MD, Luca De Rosa, MD, Claudia Cellini, MD, Pieter Sonneveld, MD, Michele Cavo, MD
Journal: Blood
Blood (2014) 124 (21): 2033.
https://doi.org/10.1182/blood.V124.21.2033.2033
Published: 2014
Journal Articles

Long-Term Molecular Results Of The Gimema VEL-03-096 Trial: Molecular Remission Achievement and Loss Are Major Outcome Predictors

Simone Ferrero, Marco Ladetto, Daniela Drandi, Federica Cavallo, Elisa Genuardi, Marina Urbano, Guglielmo Guarona, Vincenzo Callea, Clotilde Cangialosi, Tommaso Caravita, MD, Claudia Crippa, MD, Luca De Rosa, Antonietta Pia Falcone, MD, Mariella Grasso, Tommasina Guglielmelli, Anna Marina Liberati, Francesco Pisani, Patrizia Pregno, Fausto Rossini, MD, Stefania Oliva, Alberto Rocci, Roberto Passera, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2013) 122 (21): 2077.
https://doi.org/10.1182/blood.V122.21.2077.2077
Published: 2013
Journal Articles

A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients

Alessandra Larocca, MD, Sara Bringhen, MD, Andrea Evangelista, Massimo Offidani, MD, Stelvio Ballanti, MD, Alfonso Zaccaria, Norbert Pescosta, MD, Vittorio Montefusco, MD, Luca De Rosa, Angelo Michele Carella, MD, Luca Baldini, Massimo Aglietta, MD, Iolanda Donatella Vincelli, MD, Roberto Marasca, MD, Sara Pezzati, MD, Patrizia Tosi, MD, Federica Cocito, MD, Mariella Grasso, Giuseppe Fioritoni, MD, Vincenzo Pavone, Pellegrino Musto, MD, Sara Grammatico, MD, Paola Omedè, PhD, Francesca Gay, MD, Giovannino Ciccone, MD, PhD, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2013) 122 (21): 687.
https://doi.org/10.1182/blood.V122.21.687.687
Published: 2013
Journal Articles

Autologous Peripheral Blood Stem-Cell (PBSC) Collection Is Not Impaired by Bortezomib-Thalidomide-Dexamethasone (VTD) Induction Therapy in Newly Diagnosed Multiple Myeloma (MM)

Annamaria Brioli, MD, Giulia Perrone, MD, Silvestro Volpe, MD, Silvana Pasini, MD, Anna Mele, MD, Fausto Rossini, MD, Anna Marina Liberati, MD, Luca De Rosa, MD, Giuseppe Avvisati, MD, Sergio Amadori, MD, Alessandro Gozzetti, MD, Antonio Capaldi, MD, Giuseppe Mele, MD, Giuliana Farina, MD, Elena Zamagni, MD, Ernesto Vigna, MD, Silvana Capalbo, MD, Michele Magni, MD, Giuseppe Rodolfo Nunziata, MD, Monica Crugnola, MD, Vittorio Fregoni, MD, Giuliana Leopardi, MD, Immacolata Attolico, MD, Alessandro Moscetti, MD, Luigi Podda, MD, Patrizia Pregno, MD, Michele Baccarani, MD, Michele Cavo, MD
Journal: Blood
Blood (2011) 118 (21): 317.
https://doi.org/10.1182/blood.V118.21.317.317
Published: 2011
Journal Articles

LONG-TERM RESULTS of the GIMEMA VTD Consolidation TRIAL In Autografted MULTIPLE Myeloma PATIENTS (VEL-03-096): IMPACT of Minimal RESIDUAL DISEASE Detection by REAL Time Quantitative PCR On LATE Recurrences and Overall SURVIVAL

Marco Ladetto, MD, Simone Ferrero, Daniela Drandi, PhD, Federica Cavallo, Luigia Monitillo, Paola Ghione, Sara Barbiero, Mariella Grasso, Fausto Rossini, MD, Tommasina Guglielmelli, MD, Clotilde Cangialosi, MD, Anna Marina Liberati, MD, Vincenzo Callea, MD, Tommaso Caravita, MD, Luca De Rosa, MD, Francesco Pisani, Antonietta Pia Falcone, Patrizia Pregno, MD, Alberto Rocci, Roberto Passera, Mario Boccadoro, Antonio Palumbo, MD
Journal: Blood
Blood (2011) 118 (21): 827.
https://doi.org/10.1182/blood.V118.21.827.827
Published: 2011
Journal Articles

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients

Clinical Trials & Observations
Sara Bringhen, Alessandra Larocca, Davide Rossi, Maide Cavalli, Mariella Genuardi, Roberto Ria, Silvia Gentili, Francesca Patriarca, Chiara Nozzoli, Anna Levi, Tommasina Guglielmelli, Giulia Benevolo, Vincenzo Callea, Vincenzo Rizzo, Clotilde Cangialosi, Pellegrino Musto, Luca De Rosa, Anna Marina Liberati, Mariella Grasso, Antonietta P. Falcone, Andrea Evangelista, Michele Cavo, Gianluca Gaidano, Mario Boccadoro, Antonio Palumbo
Journal: Blood
Blood (2010) 116 (23): 4745–4753.
https://doi.org/10.1182/blood-2010-07-294983
Published: 2010
Journal Articles

Bortezomib, Melphalan, Prednisone and Thalidomide Followed by Maintenance with Bortezomib and Thalidomide (VMPT-VT) for Initial Treatment of Elderly Multiple Myeloma Patients: Updated Follow-up and Impact of Prognostic Factors

Antonio Palumbo, Sara Bringhen, Maide Cavalli, Roberto Ria, Massimo Offidani, Francesca Patriarca, Chiara Nozzoli, Tommasina Guglielmelli, Giulia Benevolo, Vincenzo Callea, Renato Zambello, Giuseppe Pietrantuono, Luca De Rosa, Anna Marina Liberati, Claudia Crippa, Giulia Perrone, Fabrizio Ciambelli, Angelo Michele Carella, Salvatore Palmieri, Milena Gilestro, Valeria Magarotto, Maria Teresa Petrucci, Pellegrino Musto, Gianluca Gaidano, Mario Boccadoro
Journal: Blood
Blood (2010) 116 (21): 620.
https://doi.org/10.1182/blood.V116.21.620.620
Published: 2010
Journal Articles

A Phase III Study of Enoxaparin vs Aspirin vs Low-Dose Warfarin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Thalidomide Based-Regimens.

Antonio Palumbo, MD, Michele Cavo, Sara Bringhen, Maide Cavalli, Francesca Patriarca, Davide Rossi, Paola Tacchetti, Norbert Pescosta, Claudia Crippa, Monica Galli, Tonino Spadano, Angelo Michele Carella, Tommaso Caravita, Claudia Cellini, Antonio Ledda, Francesco Pisani, Jacopo Peccatori, Francesca Elice, Andrea Nozza, Valerio De Stefano, Luca De Rosa, Anna Marina Liberati, Fabrizio Ciambelli, Giovanni De Sabbata, Lucio Catalano, Alessandra Larocca, Fortunato Morabito, Elena Zamagni, Massimo Offidani, Patrizia Tosi, Mario Boccadoro
Journal: Blood
Blood (2009) 114 (22): 492.
https://doi.org/10.1182/blood.V114.22.492.492
Published: 2009
Journal Articles

Correlation Between Clinical Outcome and Disease Kinetics by Quantitative PCR in Myeloma Patients Following Post-Transplant Consolidation with Bortezomib, Thalidomide and Dexamethasone.

Marco Ladetto, Gloria Pagliano, Simone Ferrero, Federica Cavallo, Daniela Drandi, Michela Boi, Loredana Santo, Claudia Crippa, MD, Luca De Rosa, Patrizia Pregno, Mariella Grasso, Anna Marina Liberati, Tommaso Caravita, Francesco Pisani, Tommasina Guglielmelli, Vincenzo Callea, Fausto Rossini, Pellegrino Musto, Clotilde Cangialosi, Alberto Rocci, Roberto Passera, Mario Boccadoro, Antonio Palumbo
Journal: Blood
Blood (2009) 114 (22): 960.
https://doi.org/10.1182/blood.V114.22.960.960
Published: 2009
Journal Articles

Sequential Approach with Bortezomib as Induction Before Autologous Transplantation, Followed by Lenalidomide as Consolidation-Maintenance in Untreated Multiple Myeloma Patients.

Francesca Gay, MD, Patrizia Falco, MD, Claudia Crippa, MD, Anna Marina Liberati, MD, Francesca Patriarca, MD, Clotilde Cangialosi, MD, Vincenzo Capparella, MD, Agostina Siniscalchi, MD, Manuela Rizzo, MD, Luca De Rosa, MD, Antonietta Pia Falcone, MD, Simona Caltagirone, PhD, Sara Bringhen, MD, Paolo Corradini, MD, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2009) 114 (22): 3419.
https://doi.org/10.1182/blood.V114.22.3419.3419
Published: 2009
Journal Articles

Indoleamine 2,3-Dioxygenase (IDO) Is Expressed by Multiple Myeloma Plasma Cells and Promotes the Differentiation of Regulatory T Cells: Investigations into the Role of Hepatocyte Growth Factor.

Giuseppina Bonanno, BSc, Maria Corallo, BSc, Andrea Mariotti, BSc, Anna Di Maggio, BSc, Annabella Procoli, BSc, Luca De Rosa, MD, Luca Pierelli, MD, Ignazio Majolino, MD, Giuseppe Leone, MD, Raimondo De Cristofaro, MD, Sergio Rutella, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1680.
https://doi.org/10.1182/blood.V112.11.1680.1680
Published: 2008
Journal Articles

Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients.

Marco Ladetto, Gloria Pagliano, Ilaria Avonto, Loredana Santo, Simone Ferrero, Federica Cavallo, Monica Astolfi, Patrizia Pregno, Claudia Crippa, Anna Marina Liberati, Vincenzo Callea, Luca De Rosa, Antonietta Falcone, Mariella Grasso, Daniela Drandi, Mario Boccadoro, Antonio Palumbo
Journal: Blood
Blood (2007) 110 (11): 530.
https://doi.org/10.1182/blood.V110.11.530.530
Published: 2007